Certain multiple sclerosis medications have been linked with serious side effects, including brain inflammation. Zinbryta, manufactured jointly by Biogen and Abbvie, is one of the MS medications that has been connected with brain inflammatory conditions, as well as other serious conditions including the skin disease Stevens Johnson Syndrome. Any of these major side effects can lead to permanent injuries.

Basics of Zinbryta

Zinbryta (daclizumab) is a new multiple sclerosis drug manufactured jointly by Biogen and Abbvie. Zinbryta was released onto the market after its approval by the U.S. Food and Drug Administration (FDA) in May 27, 2016.

Multiple sclerosis (MS) is a condition that involves the immune system attacking and damaging the protections around the central nervous system. Zinbryta, one of the more recent MS medications to hit the market, was meant to add options for patients who have not found two or more MS medications effective.

Zinbryta Side Effects

Unfortunately, Zinbryta has been associated with a number of serious side effects, one of the most significant of which is brain inflammation. Brain tissue inflammation is also known as encephalitis, and is often caused by a bacterial or viral infection. However, it can also be caused by an immune system disorder.

Symptoms of Zinbryta brain inflammation are similar to those of the flu, and can last for two or even three weeks. Symptoms include muscle pain, fatigue, fever, nausea or vomiting, irritability, light sensitivity, headache, seizures, and more.

Other major Zinbryta side effects include:

• Encephalitis and other immune reactions
• Liver failure and injury
• Stevens Johnson syndrome

The Zinbryta Recall

After receiving reports from patients over a slew of side effects, Zinbryta’s manufacturers issued a voluntary recall of their multiple sclerosis drug. Biogen and Abbvie announced the recall on March 2, 2018, saying that they would be removing Zinbryta from the global market because of reports of Zinbryta brain inflammation, including encephalitis and meningoencephalitis.

The manufacturers’ recall was voluntary, but the FDA has also been made aware of the complications linked with Zinbryta. The FDA has stated since the recall that it is now working closely with the manufacturers, Biogen and Abbvie, “to help ensure a well-organized withdrawal from the market in the United States, and to ensure that healthcare professionals have the information they need to carefully transition their patients using Zinbryta to another treatment.”

Filing a Lawsuit over Zinbryta Side Effects

If you or someone you love has suffered from Zinbryta brain inflammation or other side effects after exposure to MS medications, you may be able to file a lawsuit. Filing a lawsuit cannot take away the pain and suffering caused by brain inflammation and other major complications, but it can help to alleviate the financial burden caused by medical expenses and lost wages.